Bridge Builders Collaborative is a venture capital firm established in 2012 and located in Minneapolis, Minnesota. The organization is dedicated to supporting social entrepreneurs who are developing scalable applications, practices, products, and tools. With a particular focus on investments in start-ups related to mental health, consciousness, and spirituality, Bridge Builders Collaborative aims to foster innovation in these critical areas. By providing financial backing and resources, the firm seeks to empower entrepreneurs who are working to create positive social impact through their ventures.
Beckley Waves is a venture studio focused on building and investing in the psychedelic ecosystem. The company is dedicated to funding, supporting, and mentoring emerging entrepreneurs and leaders who are working to establish the operational infrastructure necessary for a global psychedelic marketplace. By facilitating connections between entrepreneurs and essential resources such as investors, advisors, and strategic partners, Beckley Waves aims to empower these innovators to thrive and achieve success in their endeavors. Through its initiatives, the company plays a crucial role in advancing the development of the psychedelic industry.
Wisdo Health
Series A in 2023
Mediscope is an innovative platform focused on addressing the challenges of social isolation and its detrimental effects on mental and physical health. By leveraging evidence-based peer support and benefits navigation, Mediscope aims to enhance health outcomes and reduce medical costs. The platform facilitates meaningful connections among users, allowing them to share experiences and gain insights from individuals who have faced similar challenges. Through its AI-powered features, Mediscope empowers individuals to navigate their health journeys more effectively, promoting engagement and community support to combat loneliness and foster well-being.
Homecoming
Seed Round in 2022
Homecoming is a provider of patient engagement tools tailored for psychedelic therapy. The company has developed a digital companion application that supports patients throughout their healing process. This application promotes accountability and long-term change by offering personalized guides, tasks, and daily check-ins, all within a user-friendly platform. It also facilitates preparation and integration support, enabling healthcare professionals to effectively guide their patients. Homecoming's focus on enhancing the therapeutic experience aims to improve outcomes for individuals undergoing psychedelic therapy.
Wavepaths
Seed Round in 2021
Wavepaths is a London-based company established in 2018 that focuses on creating innovative tools for psychedelic therapy aimed at facilitating inner exploration and personal transformation. The company develops a unique application that auto-generates individualized soundtracks for drug-free therapy sessions, integrating immersive media with advancements in intelligent technology and psychedelic science. By combining these elements, Wavepaths offers mobile tools and physical environments designed to help users reconnect with their inner resources, fostering meaningful introspection and emotional reconnection. The company's work lies at the intersection of information technology, healthcare, and personal health, emphasizing accessibility and personal growth through therapeutic experiences.
The Shift Network
Series A in 2021
The Shift Network, Inc. is a provider of virtual educational services focused on promoting personal transformation through learning. Founded in February 2010, the organization has developed a global movement centered on creating an evolutionary shift in consciousness, aimed at fostering a more enlightened society. It offers a variety of online summits and courses that cover topics such as spirituality, health, wellness, personal growth, and relationships. With a commitment to principles of sustainability, peace, health, and prosperity, The Shift Network has served over 200,000 individuals worldwide, engaging them in events and programs designed to facilitate a shift in the world’s operating system.
TRU LUV
Funding Round in 2020
TRU LUV, established in 2015 and headquartered in Toronto, Canada, specializes in designing and developing self-care application software. Its core product offers a range of digital tools, including backgrounds, paper kits, and coloring pages, aimed at promoting relaxation and stress reduction. The company's unique approach, reflected in its BENEFICENCE model and TERRA software architecture, combines elements of economics, organizational management, software development, human-computer interaction, and personal development. TRU LUV's mission is to create engaging, fun, and nourishing experiences that help users lead stress-free lives, positioning itself as a pioneering force in the intersection of technology and personal well-being.
Pear Therapeutics
Series C in 2019
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
Pear Therapeutics
Series B in 2018
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
Muse
Series B in 2017
Muse has developed brainwave-controlled computing technology and applications that converts brainwaves into digital signals. They have created a hardware and software platform technology that converts brainwaves into digital signals that are fed into a computer. InteraXon then provides consumers with applications that use these brainwaves to perform activities such as meditation, gaming, ADHD assistance, and many others to come. The company was founded in 2007 and is headquartered in Toronto, Ontario.
MeetMindful
Seed Round in 2017
MeetMindful, Inc. operates an online dating platform designed for individuals interested in health, well-being, and mindfulness. Founded in 2013 and based in Denver, Colorado, the platform connects like-minded singles, fostering a community focused on conscious dating and personal growth. In addition to facilitating connections, MeetMindful offers relationship advice from experts, helping users navigate the complexities of dating with intention and authenticity. The service encourages members to embrace the challenges of personal development while enriching their lives through meaningful connections.
eMindful
Series B in 2016
eMindful, Inc. specializes in online and mobile interactive courses focused on mindfulness and well-being. The company offers evidence-based programs that address various health-related issues, including stress, obesity, chronic pain, and smoking cessation. Through its eMindful Life platform, members can engage with one another and practice mindfulness skills daily. eMindful serves a diverse clientele, including individuals, corporations, universities, and government institutions. By partnering with Fortune 500 companies and leading health plans, eMindful aims to improve health outcomes, reduce healthcare costs, and enhance workforce engagement. Founded in 2003 and based in Orlando, Florida, eMindful has evolved from its original name, McCabe Consulting Associates Inc., in 2008, and operates technical support facilities across the United States.
Pear Therapeutics
Series A in 2016
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
Twill
Convertible Note in 2015
Twill is a healthcare platform focused on enhancing mental and physical wellness. It offers a software solution that employs web and mobile technology to evaluate users' happiness through both subjective and objective assessments. The platform includes various programs and games designed to promote healthier mindsets. By addressing issues such as stress, depression, anxiety, and social isolation, Twill aims to support individuals, employers, and care delivery systems in managing the challenges associated with chronic illness.
Muse
Series A in 2013
Muse has developed brainwave-controlled computing technology and applications that converts brainwaves into digital signals. They have created a hardware and software platform technology that converts brainwaves into digital signals that are fed into a computer. InteraXon then provides consumers with applications that use these brainwaves to perform activities such as meditation, gaming, ADHD assistance, and many others to come. The company was founded in 2007 and is headquartered in Toronto, Ontario.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.